A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort

Neurology

Volumn 66, Issue 12, 2006, Pages 1888-1893

  Baumber, L ^a,e   Sjostrand C ^b   Leone, M ^c   Harty, H ^a   Bussone, G ^c   Hillert, J ^b   Trembath, R C ^a,e,f   Russell, M B ^d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN 2 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME; CLUSTER HEADACHE; CONTROLLED STUDY; DENMARK; EUROPE; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; HYPOCRETIN RECEPTOR 2 GENE; ITALY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; STATISTICAL ANALYSIS; SWEDEN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CLUSTER HEADACHE; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RISK ASSESSMENT; RISK FACTORS; VARIATION (GENETICS);

EID: 33745895274     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000219765.95038.d7     Document Type: Article

References (45)

1. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002;58:354-361.
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004;24(suppl 1):1-160.
3. Manzoni GC, Micieli G, Granella F, Tassorelli C, Zanferrari C, Cavallini A. Cluster headache course over ten years in 189 patients. Cephalalgia 1991;11:169-174.
4. Tonon C, Guttmann S, Volpini M, Naccarato S, Cortelli P, D'Alessandro R. Prevalence and incidence of cluster headache in the Republic of San Marino. Neurology 2002;58:1407-1409.
5. Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vågå study of headache epidemiology. Cephalalgia 2003;23:528-533.
6. Torelli P, Beghi E, Manzoni GC. Cluster headache prevalence in the Italian general population. Neurology 2005;64:469-474.
7. Manzoni GC. Male preponderance of cluster headache is progressively decreasing over the years. Headache 1997;37:588-589.
8. Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurol 2004;3:279-283.
9. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994;117:427-434.
10. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998;352:275-278.
11. Chazot G, Claustrat B, Brun J, Jordan D, Sassolas G, Schott B. A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache. Cephalalgia 1984;4:213-220.
12. Waldenlind E, Ekbom K, Wetterberg L, et al. Lowered circannual urinary melatonin concentrations in episodic cluster headache. Cephalalgia 1994;14:199-204.
13. Strittmatter M, Hamann GF, Grauer M, et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. Neuroreport 1996;7:1229-1234.
14. Leone M, Lucini V, D'Amico D, et al. Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache. Cephalalgia 1998;18:664-667.
15. Sprenger T, Boecker H, Tolle TR, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology 2004;62:516-517.
16. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med 2001;345:1428-1429.
17. Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery 2003;52:1095-1099.
18. Russell MB, Andersson PG, Thomsen LL, Iselius L. Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis. J Med Genet 1995;32:954-956.
19. Svensson DA, Ekbom K, Pedersen NL, Traff H, Waldenlind E. A note on cluster headache in a population-based twin register. Cephalalgia 2003;23:376-380.
20. Shimomura T, Kitano A, Marukawa H, et al. Point mutation in platelet mitochondrial tRNA(Leu(UUR)) in patient with cluster headache. Lancet 1994;344:625.
21. Odawara M, Tamaoka A, Mizusawa H, Yamashita K. A case of cluster headache associated with mitochondrial DNA deletions. Muscle Nerve 1997;20:394-395.
22. Cortelli P, Zacchini A, Barboni P, Malpassi P, Carelli V, Montagna P. Lack of association between mitochondrial tRNA(Leu(UUR)) point mutation and cluster headache. Lancet 1995;345:1120-1121.
23. Seibel P, Grunewald T, Gundolla A, Diener HC, Reichmann H. Investigation on the mitochondrial transfer RNA(Leu)(UUR) in blood cells from patients with cluster headache. J Neurol 1996;243:305-307.
24. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-552.
25. Jodice C, Mantuano E, Veneziano L, et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997;6:1973-1978.
26. Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997;15:62-69.
27. Sjöstrand C, Giedratis V, Ekbom K, Waldenlind E, Hillert J. CACNA1A gene polymorphisms in cluster headache. Cephalalgia 2001;21:953-958.
28. Sjöstrand C, Modin H, Masterman T, Ekbom K, Waldenlind E, Hillert J. Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia 2002;22:758-764.
29. Haan J, van Vliet JA, Kors EE, et al. No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. Cephalalgia 2001;21:959-962.
30. De Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95:322-327.
31. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
32. Rainero I, Gallone S, Valfre W, et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 2004;63:1286-1288.
33. Leone M, Russell MB, Rigamonti A, et al. Increased familial risk of cluster headache. Neurology 2001;56:1233-1236.
34. Sjöstrand C, Russell MB, Ekbom K, Hillert J, Waldenlind E. Familial cluster headache. Is atypical cluster headache in family members part of the clinical spectrum? Cephalalgia 2005;25:1068-1077.
35. Jeffreys AJ, Ritchie A, Neumann R. High-resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot. Hum Mol Genet 2000;9:725-733.
36. Ott J. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci USA 1989;86:4175-4178.
37. Weeks DE, Ott J, Lathrop GM. SLINK: a general simulation program for linkage analysis. Am J Hum Genet 1990;47:A204 (suppl).
38. Markianos K, Daly MJ, Kruglyak L. Efficient multipoint linkage analysis through reduction of inheritance space. Am J Hum Genet 2001;68:963-977.
39. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
40. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003;33:192-196.
41. Wessman M, Kaunisto MA, Kallela M, Palotie A. The molecular genetics of migraine. Ann Med 2004;36:462-473.
42. Russo L, Mariotti P, Sangiorgi E, et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet 2005;76:327-333.
43. Lea RA, Nyholt DR, Curtain RP, et al. A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 2005;6:67-72.
44. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-99.
45. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004;75:353-362.